Therefore, by suppressing the overrelease of endogenous Aβ42/Aβ42-os in the presence of Aβs + CMT, NPS 2143 further highlighted the potential roles of Aβ•CaSR signalling in AD development. Here, CASR is linked to Alzheimer disease.